Delivery Order SPE2DB22D3009-SPE2DB24FBA74
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTZC2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a $1,025.18 firm-fixed-price delivery order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a January 16, 2025 completion date and was awarded on January 15, 2025. AmerisourceBergen Drug Corp is the prime contractor and is a major pharmaceutical distributor and healthcare solutions provider. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,700.17, is a Delivery Order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a firm fixed price pricing type and an ultimate completion date of December 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDKU8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,145.65 Firm Fixed Price delivery order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of November 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, SPE2DB22D1106|SPE2DB24FFAD3, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,547.50, is a delivery order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. It has a firm fixed price and an ultimate completion date of July 3, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, with the ID SPE2DB20D1100|SPE2DB25FY86J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,040.68 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.67 delivery order contract is a Firm Fixed Price type with a completion date of September 22, 2023. The contract provides the DLA with the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S". This award does not have a set-aside designation, indicating open competition. Amerisourcebergen also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.61 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,509.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award with ID SPE2DB20D3505|SPE2DB23FU0A5 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,746.92 delivery order is for the supply of the medical product XULANE 150-35 MCG/DAY PATCH 3S. This award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...
This federal contract award, valued at $1,340.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D2002|SPE2DB25FL19H) with a firm fixed price pricing type, and an ultimate completion date of February 13, 2025. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This award is not designated as a set-aside...